Segmentation methods and dosimetric evaluation of 3D-printed immobilization devices in head and neck radiotherapy.

IF 3.4 2区 医学 Q2 ONCOLOGY BMC Cancer Pub Date : 2025-02-18 DOI:10.1186/s12885-025-13669-0
Yunpeng Yin, Weisha Zhang, Lian Zou, Xiangxiang Liu, Luxin Yu, Ming Wang
{"title":"Segmentation methods and dosimetric evaluation of 3D-printed immobilization devices in head and neck radiotherapy.","authors":"Yunpeng Yin, Weisha Zhang, Lian Zou, Xiangxiang Liu, Luxin Yu, Ming Wang","doi":"10.1186/s12885-025-13669-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Treatment planning systems (TPS) often exclude immobilization devices from optimization and calculation, potentially leading to inaccurate dose estimates. This study employed deep learning methods to automatically segment 3D-printed head and neck immobilization devices and evaluate their dosimetric impact in head and neck VMAT.</p><p><strong>Methods: </strong>Computed tomography (CT) positioning images from 49 patients were used to train the Mask2Former model to segment 3D-printed headrests and MFIFs. Based on the results, four body structure sets were generated for each patient to evaluate the impact on dose distribution in volumetric modulated arc therapy (VMAT) plans: S (without immobilization devices), S<sub>_MF</sub> (with MFIFs), S<sub>_3D</sub> (with 3D-printed headrests), and S<sub>_3D+MF</sub> (with both). VMAT plans (P, P<sub>_MF</sub>, P<sub>_3D</sub>, and P<sub>_3D+MF</sub>) were created for each structure set. Dose-volume histogram (DVH) data and dose distribution of the four plans were compared to assess the impact of the 3D-printed headrests and MFIFs on target and normal tissue doses. Gafchromic EBT3 film measurements were used for patient-specific verification to validate dose calculation accuracy.</p><p><strong>Results: </strong>The Mask2Former model achieved a mean average precision (mAP) of 0.898 and 0.895, with a Dice index of 0.956 and 0.939 for the 3D-printed headrest on the validation and test sets, respectively. For the MFIF, the Dice index was 0.980 and 0.981 on the validation and test sets, respectively. Compared to P, P<sub>_MF</sub> reduced the V<sub>100%</sub> for PGTVnx, PGTVnd, PGTVrpn, PTV1, and PTV2 by 5.99%, 6.51%, 5.93%, 2.24%, and 1.86%, respectively(P ≤ 0.004). P<sub>_3D</sub> reduced the same targets by 1.78%, 2.56%, 1.75%, 1.16%, and 1.48%(P < 0.001), with a 31.3% increase in skin dose (P < 0.001). P<sub>_3D+MF</sub> reduced the V<sub>100%</sub> by 9.15%, 10.18%, 9.16%, 3.36%, and 3.28% (P < 0.001), respectively, while increasing the skin dose by 31.6% (P < 0.001). EBT3 film measurements showed that the P<sub>_3D+MF</sub> dose distribution was more aligned with actual measurements, achieving a mean gamma pass rate of 92.14% under the 3%/3 mm criteria.</p><p><strong>Conclusions: </strong>This study highlights the potential of Mask2Former in 3D-printed headrest and MFIF segmentation automation, providing a novel approach to enhance personalized radiation therapy plan accuracy. The attenuation effects of 3D-printed headrests and MFIFs reduce V<sub>100%</sub> and D<sub>mean</sub> for PTVs in head and neck cancer patients, while the buildup effects of 3D-printed headrests increases the skin dose (31.3%). Challenges such as segmentation inaccuracies for small targets and artifacts from metal fasteners in MFIFs highlight the need for model optimization and validation on larger, more diverse datasets.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"289"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11837297/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-13669-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Treatment planning systems (TPS) often exclude immobilization devices from optimization and calculation, potentially leading to inaccurate dose estimates. This study employed deep learning methods to automatically segment 3D-printed head and neck immobilization devices and evaluate their dosimetric impact in head and neck VMAT.

Methods: Computed tomography (CT) positioning images from 49 patients were used to train the Mask2Former model to segment 3D-printed headrests and MFIFs. Based on the results, four body structure sets were generated for each patient to evaluate the impact on dose distribution in volumetric modulated arc therapy (VMAT) plans: S (without immobilization devices), S_MF (with MFIFs), S_3D (with 3D-printed headrests), and S_3D+MF (with both). VMAT plans (P, P_MF, P_3D, and P_3D+MF) were created for each structure set. Dose-volume histogram (DVH) data and dose distribution of the four plans were compared to assess the impact of the 3D-printed headrests and MFIFs on target and normal tissue doses. Gafchromic EBT3 film measurements were used for patient-specific verification to validate dose calculation accuracy.

Results: The Mask2Former model achieved a mean average precision (mAP) of 0.898 and 0.895, with a Dice index of 0.956 and 0.939 for the 3D-printed headrest on the validation and test sets, respectively. For the MFIF, the Dice index was 0.980 and 0.981 on the validation and test sets, respectively. Compared to P, P_MF reduced the V100% for PGTVnx, PGTVnd, PGTVrpn, PTV1, and PTV2 by 5.99%, 6.51%, 5.93%, 2.24%, and 1.86%, respectively(P ≤ 0.004). P_3D reduced the same targets by 1.78%, 2.56%, 1.75%, 1.16%, and 1.48%(P < 0.001), with a 31.3% increase in skin dose (P < 0.001). P_3D+MF reduced the V100% by 9.15%, 10.18%, 9.16%, 3.36%, and 3.28% (P < 0.001), respectively, while increasing the skin dose by 31.6% (P < 0.001). EBT3 film measurements showed that the P_3D+MF dose distribution was more aligned with actual measurements, achieving a mean gamma pass rate of 92.14% under the 3%/3 mm criteria.

Conclusions: This study highlights the potential of Mask2Former in 3D-printed headrest and MFIF segmentation automation, providing a novel approach to enhance personalized radiation therapy plan accuracy. The attenuation effects of 3D-printed headrests and MFIFs reduce V100% and Dmean for PTVs in head and neck cancer patients, while the buildup effects of 3D-printed headrests increases the skin dose (31.3%). Challenges such as segmentation inaccuracies for small targets and artifacts from metal fasteners in MFIFs highlight the need for model optimization and validation on larger, more diverse datasets.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
3d打印头颈部放疗固定装置的分割方法及剂量学评价。
背景:治疗计划系统(TPS)通常将固定装置排除在优化和计算之外,可能导致不准确的剂量估计。本研究采用深度学习方法对3d打印头颈部固定装置进行自动分割,并评估其在头颈部VMAT中的剂量学影响。方法:利用49例患者的CT定位图像,训练Mask2Former模型对3d打印头枕和MFIFs进行分割。在此基础上,为每位患者生成了四组身体结构集,以评估体积调制电弧治疗(VMAT)计划对剂量分布的影响:S(无固定装置)、S_MF(带MFIFs)、S_3D(带3d打印头枕)和S_3D+MF(两者都有)。为每个结构集创建VMAT图(P、P_MF、P_3D和P_3D+MF)。比较四种方案的剂量-体积直方图(DVH)数据和剂量分布,以评估3d打印头枕和MFIFs对目标和正常组织剂量的影响。Gafchromic EBT3薄膜测量用于患者特异性验证,以验证剂量计算的准确性。结果:Mask2Former模型在验证集和测试集上3d打印头枕的平均精度(mAP)分别为0.898和0.895,Dice指数分别为0.956和0.939。对于MFIF,在验证集和测试集上的Dice指数分别为0.980和0.981。与P相比,P_MF使PGTVnx、PGTVnd、PGTVrpn、PTV1和PTV2的V100%分别降低5.99%、6.51%、5.93%、2.24%和1.86% (P≤0.004)。P_3D对相同靶标的降低率分别为1.78%、2.56%、1.75%、1.16%和1.48%(P _3D+MF对V100%的降低率分别为9.15%、10.18%、9.16%、3.36%和3.28%)(P _3D+MF的剂量分布更符合实际测量值,在3%/3 mm标准下,平均伽马及格率为92.14%。结论:本研究强调了Mask2Former在3d打印头枕和MFIF分割自动化中的潜力,为提高个性化放射治疗计划的准确性提供了一种新的方法。3d打印头枕和MFIFs的衰减效应使头颈癌患者ptv的V100%和Dmean降低,而3d打印头枕的累积效应使皮肤剂量增加(31.3%)。MFIFs中的小目标和金属紧固件工件的分割不准确等挑战突出了对更大、更多样化数据集的模型优化和验证的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
期刊最新文献
Efficacy and safety of albumin-bound paclitaxel combined with anlotinib and immunotherapy in advanced non-small cell lung cancer with liver metastases: a retrospective study. Personalized Prediction of prognosis in ebv-associated lymphoepithelioma-like carcinoma: insights from a Chinese cohort study. Exploration of patients and multidisciplinary point of view about the self-care needs of patients with a stoma: a qualitative study. Dose-effect relationship of D90 in iodine-125 seed implantation for advanced lung cancer: gradient-based efficacy and survival outcome. Clinical and biomarker predictors of early and late recurrence in hormone receptor-positive breast cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1